| News

Interest from startups in the BaseLaunch healthcare accelerator exceeds expectations

25.07.2017

More than 100 projects from Switzerland and abroad competed for a place in the BaselArea.swiss accelerator program for healthcare startups.

By the closing date of June 30, the BaseLaunch startup accelerator received 112 applications. 77 percent of the projects were from Europe, with a total of 45 percent from Switzerland and 25 projects from the rest of the world. A third of applications involved therapeutics, 20 percent were concerned with diagnostics, and 18 percent with digital healthcare and healthcare services. Other projects focused on therapeutic platforms and services, medtech, and related fields. BaseLaunch offers startups infusions of funds, insight, infrastructure and industry access, and integrates them into one of the most dynamic biotech and healthcare ecosystems in Europe. The accelerator program initiated and operated by BaselArea.swiss aims to attract the next generation of successful healthcare companies by harnessing the unique position of the Basel region as a global life sciences hub. BaseLaunch is backed by healthcare partners Novartis Venture Fund, Johnson & Johnson Innovation and Pfizer. BaseLaunch also collaborates with digitalswitzerland as a healthcare vertical of Kickstart Accelerator.

Positive response to the call for applications
“The number of applicants far exceeded our expectations,” says Alethia de León, Managing Director of BaseLaunch. “We now have the task of selecting up to ten of the most promising projects for the first phase.” A selection committee made up of industry experts will be responsible for the selection process. Ventures accepted for the first phase of the program will receive grants of up to 10,000 Swiss francs beginning in September 2017. They will then have three months to develop their business ideas in close collaboration with the BaseLaunch team and a network of experienced entrepreneurs. Up to three startups will be selected from these companies for the second phase. They will each receive up to 250,000 Swiss francs and the opportunity to generate research data for one year in the laboratory of the Switzerland Innovation Park Basel Area and thereby achieve milestones in their business plan. Experts will also be available to advise and mentor during this time.

For Christof Klöpper, CEO of BaselArea.swiss, the large number of applications from abroad is a sure sign of the Basel region’s international reputation as a world-leading life sciences center. BaselArea.swiss has passed on to BaseLaunch all of its expertise in promoting innovation and investment. “We have many years of experience of networking innovators in the local area and supporting entrepreneurs by identifying suitable partners. BaseLaunch takes full advantage of this expertise, which is particularly valuable to participants from outside the region.”

The selected startups for the first phase will be announced in late summer.

For more information, please visit the BaseLaunch website.

Important dates:

Phase I: September 15 – December 7, 2017

Phase II: January 2 – December 21, 2018

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Novartis Campus
Basel Area Business & Innovation, Switzerland Innovation Park

Switzerland Innovation Park Basel Area Site Novartis Campus

We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.

Read More
Basel Area Business & Innovation, Switzerland Innovation Park

The innovation and enterprise campus GRID is filling up

Two institutes from the University of Basel and a pharmaceutical company are relocating to the GRID innovation and enterprise campus, which is currently under construction at BaseLink in Allschwil. The new building will also contain the headquarters of the Switzerland Innovation Park Basel Area in future.

Read More
Basel Area Business & Innovation, Innovation

Artidis ends successful study

Artidis, a startup from Basel, has developed a nanotechnology platform that can be used for cancer diagnosis, among other things. The platform has now been tested in a study that was able to achieve its primary endpoint.

Read More
Basel Area Business & Innovation, Innovation

Startup Academy celebrates anniversary

Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to date. The project was originally started in Basel and is now represented at several locations in Switzerland with plans for further growth.

Read More
Basel Area Business & Innovation, Invest

Syngenta grows strongly and stays true to Basel

Syngenta AG, Adama and Sinochem are to be united under the umbrella of the new Syngenta Group. The group is headquartered in Basel and employs around 48,000 staff across over 100 countries.

Read More
Basel Area Business & Innovation, Innovation

Tolremo raises additional funding

The Muttenz-based biotechnology company Tolremo Therapeutics has raised an additional 4.7 million Swiss francs as part of a financing round. The company develops cancer therapies for precision medicine and is now driving forward clinical development.

Read More
Ruben Herrendorff, CEO Polyneuron Pharmaceuticals
Basel Area Business & Innovation, Innovation

Polyneuron medication receives orphan drug status in the USA

The American health authority has granted Polyneuron’s drug PN-1007 orphan designation. This status uses special conditions to balance out commercial disadvantages when developing drugs for rare diseases.

Read More
Basel Area Business & Innovation, Innovation

BaseLaunch Applications open

BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.

Read More
Basel Area Business & Innovation, Innovation

i4Challenge Applications open

The i4Challenge is an acceleration program for SME, startups and new projects focused on innovative solutions, new approaches and next-generation products or services for Industry 4.0.

Read More
Basel Area Business & Innovation, Invest

Ricola earns the trust of Switzerland

Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.

Read More
1 2 3 19

Do you have a question? We'd like to hear from you.